Skip to main content
. 2021 May 2;14(4):1197–1200. doi: 10.1111/cts.12995

Table 1.

Comparison of medications known to contain NDMA

Medication Highest NDMA level, µg, per dose Maximum daily dosing, mg Cause of NDMA FDA response
Ranitidine 0.86 per 300 mg 300 Undetermined but increases with application of heat Complete market withdrawal
Nizatidine 0.02 per 150 mg 300 Undetermined Voluntary recalls of affected products
Irbesartan Unpublished 300 Manufacturing process Voluntary recalls of affected products
Losartan Unpublished 100 Manufacturing process Voluntary recalls of affected products
Valsartan 20.19 per 320 mg 320 Manufacturing process Voluntary recalls of affected products
Metformin a 0.19 per 500 mg 2000 Undetermined Voluntary recalls of affected products

Comparison of NDMA levels of affected medications and cause of impurity as reported by the FDA as well as agency response. 4 , 6 , 8 Typical maximum daily dosing of oral products is reported.

Abbreviations: FDA, US Food and Drug Administration; NDMA, N‐nitrosodimethylamine.

a

Extended‐release formation.